Sabra Healthcare REIT (NASDAQ:SBRA) Updates FY 2026 Earnings Guidance

Sabra Healthcare REIT (NASDAQ:SBRA) issued an update on its FY 2026 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 1.530-1.550 for the period, compared to the consensus earnings per share estimate of 1.500. The company issued revenue guidance of -.

Sabra Healthcare REIT Stock Performance

SBRA traded up $1.14 on Tuesday, reaching $21.14. The company had a trading volume of 799,745 shares, compared to its average volume of 2,727,264. The company has a quick ratio of 4.72, a current ratio of 4.72 and a debt-to-equity ratio of 0.96. The stock has a market capitalization of $5.33 billion, a PE ratio of 33.56, a P/E/G ratio of 1.50 and a beta of 0.65. The stock has a 50-day moving average price of $19.59 and a 200-day moving average price of $19.76. Sabra Healthcare REIT has a 1 year low of $17.17 and a 1 year high of $21.28.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its quarterly earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 EPS for the quarter, meeting the consensus estimate of $0.16. The business had revenue of $211.74 million during the quarter, compared to analysts’ expectations of $209.20 million. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.The company’s quarterly revenue was up 20.9% compared to the same quarter last year. During the same period last year, the firm earned $0.37 EPS. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. As a group, research analysts forecast that Sabra Healthcare REIT will post 1.5 EPS for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, May 29th. Shareholders of record on Friday, May 15th were given a $0.30 dividend. The ex-dividend date of this dividend was Friday, May 15th. This represents a $1.20 annualized dividend and a yield of 5.7%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is 190.48%.

Wall Street Analyst Weigh In

Several research firms recently commented on SBRA. Weiss Ratings cut Sabra Healthcare REIT from a “buy (b+)” rating to a “buy (b)” rating in a research note on Thursday, June 4th. Wall Street Zen upgraded Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research note on Sunday, June 28th. Truist Financial upgraded shares of Sabra Healthcare REIT from a “hold” rating to a “buy” rating and set a $22.00 price target for the company in a research note on Wednesday, July 8th. Wells Fargo & Company raised their price objective on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the stock an “overweight” rating in a report on Monday, June 1st. Finally, UBS Group cut their target price on shares of Sabra Healthcare REIT from $22.00 to $21.00 and set a “neutral” rating on the stock in a research note on Wednesday, July 8th. Five research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $21.45.

Institutional Investors Weigh In On Sabra Healthcare REIT

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Balyasny Asset Management L.P. acquired a new stake in Sabra Healthcare REIT during the 2nd quarter worth about $49,955,000. Freestone Grove Partners LP acquired a new stake in shares of Sabra Healthcare REIT during the fourth quarter worth approximately $34,862,000. Millennium Management LLC grew its position in Sabra Healthcare REIT by 197.5% during the fourth quarter. Millennium Management LLC now owns 2,668,429 shares of the real estate investment trust’s stock valued at $50,540,000 after purchasing an additional 1,771,342 shares in the last quarter. Nuveen LLC increased its stake in Sabra Healthcare REIT by 28.6% in the 4th quarter. Nuveen LLC now owns 7,303,254 shares of the real estate investment trust’s stock valued at $138,324,000 after buying an additional 1,625,072 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new stake in Sabra Healthcare REIT in the 4th quarter worth approximately $28,512,000. Institutional investors and hedge funds own 99.40% of the company’s stock.

About Sabra Healthcare REIT

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net?lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long?term, triple?net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post?acute rehabilitation and research and development laboratories.